464.90
Alnylam Pharmaceuticals Inc Aktie (ALNY) Neueste Nachrichten
Using data filters to optimize entry into Alnylam Pharmaceuticals Inc.Earnings Overview Summary & Real-Time Chart Pattern Alerts - newser.com
What downside risks could hit Alnylam Pharmaceuticals Inc. (DUL) stockJuly 2025 Retail & Safe Capital Investment Plans - newser.com
Custom watchlist performance reports with Alnylam Pharmaceuticals Inc.2025 Market Outlook & Daily Stock Momentum Reports - newser.com
Is Alnylam Pharmaceuticals Inc. (DUL) stock vulnerable to rate hikesInflation Watch & Long Hold Capital Preservation Plans - newser.com
Published on: 2025-10-21 18:00:20 - newser.com
Published on: 2025-10-21 15:17:29 - newser.com
Are Alnylam Shares Still Attractive After a 110% Surge and Fresh Pipeline News? - simplywall.st
Alnylam Pharmaceuticals, Inc. (ALNY) stock price, news, quote and history - Yahoo
Will Alnylam Pharmaceuticals Inc. (DUL) stock sustain bullish trend into 2025Trend Reversal & Risk Adjusted Buy/Sell Alerts - newser.com
Is Alnylam Pharmaceuticals Inc. reversing from oversold territoryMarket Risk Report & Long-Term Growth Stock Strategies - newser.com
Is it time to cut losses on Alnylam Pharmaceuticals Inc.Weekly Profit Report & Community Verified Trade Signals - newser.com
How to recover losses in Alnylam Pharmaceuticals Inc. stockPortfolio Performance Summary & Weekly High Potential Stock Alerts - newser.com
Will Alnylam Pharmaceuticals Inc. stock sustain high P E ratios2025 Volatility Report & Growth Focused Entry Point Reports - newser.com
Why Alnylam (ALNY) Might be Well Poised for a Surge - sharewise.com
ALNY (Alnylam Pharmaceuticals) Equity-to-Asset : 0.06 (As of Jun. 2025) - GuruFocus
Alnylam Pharmaceuticals, Inc. (ALNY) Stock Analysis: Navigating Growth Amidst a Potential -5.64% Downside - DirectorsTalk Interviews
News impact scoring models applied to Alnylam Pharmaceuticals Inc.2025 EndofYear Setup & AI Driven Stock Movement Reports - newser.com
A Fresh Look at Alnylam Pharmaceuticals (ALNY) Valuation Following Strong Pipeline Momentum - simplywall.st
What drives Imagi International Holdings Limited BOI7 stock priceShort-Term Trading Alerts & Affordable Investment Strategies - earlytimes.in
ALNY (Alnylam Pharmaceuticals) Cash Ratio : 2.20 (As of Jun. 2025) - GuruFocus
Is Alnylam Pharmaceuticals Inc. (DUL) stock attractive for dividend growthGap Up & Real-Time Volume Triggers - nchmf.gov.vn
Why Alnylam Pharmaceuticals Inc. stock is recommended by analysts2025 Trading Recap & Growth Focused Entry Reports - newser.com
Alnylam price target raised to $535 from $459 at Truist - Yahoo Finance
Is Alnylam Pharmaceuticals Inc. stock ready for breakout2025 Pullback Review & Safe Entry Momentum Stock Tips - nchmf.gov.vn
Alnylam Pharmaceuticals, Inc.Common Stock (NQ: ALNY - FinancialContent
What to do if you’re stuck in Alnylam Pharmaceuticals Inc.2025 EndofYear Setup & Verified Trade Idea Suggestions - newser.com
Truist Securities Raises Price Target for Alnylam Pharmaceuticals (ALNY) by 16.56% | ALNY Stock News - GuruFocus
Alnylam stock price target raised to $535 from $459 by Truist Securities - Investing.com
Alnylam to Webcast Conference Call Discussing Third Quarter 2025 Financial Results - BioSpace
ALNY (Alnylam Pharmaceuticals) Cash-to-Debt : 2.20 (As of Jun. 2025) - GuruFocus
Alnylam Pharmaceuticals Hits New 52-Week High of $485.28 - Markets Mojo
Alnylam Pharmaceuticals (ALNY): Assessing Valuation Following New Partnerships, Pipeline Progress, and Fresh Financing - Yahoo Finance
Responsive Playbooks and the ALNY Inflection - news.stocktradersdaily.com
Is the Options Market Predicting a Spike in Alnylam Pharmaceuticals Stock? - sharewise.com
Alnylam Pharmaceuticals stock hits all-time high at 484.5 USD By Investing.com - Investing.com Nigeria
Are You Looking for a Top Momentum Pick? Why Alnylam Pharmaceuticals (ALNY) is a Great Choice - Yahoo Finance
Alnylam Pharmaceuticals stock hits all-time high at 484.5 USD - Investing.com
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):